80岁及以上高龄成人头颈部鳞状细胞癌根治性治疗的结果
回顾性研究比较114例≥80岁与70-79岁头颈部鳞状细胞癌患者根治性治疗后的结局。70-79岁组中位总生存期35个月(95%CI 19.58-50.42)高于≥80岁组19个月(11.72-26.28;p=0.008),但无病生存率和局部区域控制相似。KPS<90是总生存期的独立预后因素(HR=2.14 [1.05-4.38])。
要点
- ≥80岁组中位总生存期19个月,低于70-79岁组的35个月(p=0.008)。
- 两年龄组无病生存率和局部区域控制相似。
- KPS<90是总生存期的独立预后因素(HR=2.14 [1.05-4.38])。
核心结论
- 高龄头颈部鳞状细胞癌患者(≥80岁)接受根治性治疗可获得良好结局,仅凭高龄不应禁止患者接受治疗。
- 体能状态可能比年龄本身更能预测生存结局。
研究设计与样本
- 回顾性研究,纳入114例诊断为头颈部鳞状细胞癌的患者。
- 比较≥80岁与70-79岁患者的总生存期、无病生存率和局部区域控制,并校正混杂因素。
主要发现
- 70-79岁组中位总生存期35个月(95%CI 19.58-50.42),≥80岁组19个月(11.72-26.28;p=0.008)。
- 两年龄组无病生存率和局部区域控制相似。
- KPS<90是总生存期的独立预后因素(HR=2.14 [1.05-4.38])。
关键数值与推荐
- 证据等级为Level III。
- KPS<90是总生存期的独立预后因素(HR=2.14 [1.05-4.38])。
临床怎么用
- 作者认为,高龄头颈部鳞状细胞癌患者(≥80岁)接受根治性治疗可获得良好结局,仅凭高龄不应禁止患者接受治疗。
- 作者认为,体能状态可能比年龄本身更能预测生存结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Head and neck cancer treatment can be difficult and advancing age is associated with greater frailty. It is unclear if curative treatment for very elderly patients is beneficial. This study compared outcomes to curative treatment in patients ≥80 aged with HNSCC to patients aged 70-79. METHODS: Retrospective study of 114 patients diagnosed with HNSCC. Overall survival (OS), Disease-Free Survival (DFS), and local-regional control (LRC) were compared and adjusted for confounders. RESULTS: Patients aged 70-79 had a higher median OS (35 months [95% CI, 19.58-50.42]) compared with patients aged ≥80 (19 months [11.72-26.28]; p = 0.008) but similar DFS and LRC. KPS < 90 was the stand-alone independent prognostic factor for OS (HR = 2.14 [1.05-4.38]). CONCLUSION: Very elderly HNSCC patients (aged ≥80) can have favorable outcomes with curative therapy and advanced chronological age alone should not prohibit patients from receiving treatment. Performance status may be a greater predictor of survival outcome than age alone. LEVEL OF EVIDENCE: Level III.
引用
- Wilson T, Fleischer L, Patel S, et al. Outcomes of curative treatment for head and neck squamous cell carcinoma in very elderly adults ≥80 years old. Head Neck. 2022. PMID: 35822453. doi:10.1002/hed.27141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。